Astal Laboratories to Hold Board Meeting to Approve Q1 Financial Results
Astal Laboratories Ltd has scheduled a Board of Directors meeting for Friday, August 14, 2026, at its corporate office. The primary agenda item for the meeting is the review and approval of the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.The Board meeting, which is set to take place at the company's Telangana office, will also consider any other matter with the permission of the chair. The financial results are slated to be reviewed alongside the Limited Review Report provided by the auditors.
In compliance with insider trading regulations, Astal Laboratories announced that the Trading Window for Designated Persons and their immediate relatives is closed. This restriction commenced on July 01, 2026, and will remain in effect until forty-eight hours following the conclusion of the Board of Directors meeting.
Stock Price Movement
Astal Laboratories Ltd settled at ₹81.29 on Friday, edging higher by 0.17%. The stock experienced movement during the session, trading between an intraday low of ₹80.36 and a high of ₹83.90.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.